Optimized Curcumin for Enhanced Absorption*
- Allows slow breakdown by the body
- Mild dose-optimized curcumin from turmeric
- Remains in the bloodstream for up to 24 hours
$39.96 — subscription plans starting at $39.96 / month
Millions of Americans are affected by some kind of joint issue each year, yet most of us don’t think about our joints until we start feeling discomfort regularly. In many cases, joint issues are related to the body’s inflammatory response triggered by our lifestyle and diet. That’s why, along with establishing good habits and leading a healthy lifestyle, supplementing with curcumin may provide the necessary support.
While the power and medicinal properties of curcumin have been revered in India since ancient times, we now know that the wonder herb has one flaw: It is difficult for the body to absorb and therefore, to reap its many benefits. Because curcumin can only dissolve in fat–not water–once it reaches our digestive system, most of it is eliminated and not used by the body.
Because bioavailability and absorption help determine effectiveness, the key to an optimal supplement is for the curcumin to have the ability to remain in a free state. The CurcuVIVA™ premium formula provides free-state curcumin that retains its “unbroken” form, which makes it stable, concentrated, and able to retain maximum effectiveness for up to 24 hours.
CurcuVIVA™ also utilizes the medicinal properties of curcumin to help maintain healthy digestion, liver, and gallbladder.
Curcumin is a key component in turmeric root, traditionally used in Ayurvedic medicine. CurcuVIVA™ is a highly absorbable curcumin formula that is free from rapid excretion.*
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, sesame seeds, sulfites, mustard, dairy, eggs, fish, shellfish or any animal byproduct.
Take 1 capsule per day with/without food, or as directed by a qualified health care practitioner.
Consult your physician before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication. Keep out of reach of children.
- Immune health support
- Cognitive support
- Cellular growth and differentiation
- Lipid metabolism
- Gastrointestinal health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
† Daily Value not established.
Other Ingredients: organic rice hull, capsule (hypromellose and purified water), stearic acid, maltodextrin, soy lecithin, ascorbyl palmitate, silicon dioxide, palm oil, and sodium stearyl fumarate.
*LONGVIDA® is a registered trademark of Verdure Sciences Inc. International patent pending.
Begum et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease. J Pharmacol Exp Ther. 2008 Jul;326(1):196-208.
Dadhaniya P, Patel C, Muchhara J, Bhadja N, Mathuria N, Vachhani K, Soni MG. Chronic safety of Longvida. Food Chem Toxicol. 2011 May 6.
Disilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012 Sep 26;11:79.
Frautschy, SA. Bioavailability, brain concentrations, activity and dose-response of Longvida® SLCP. 38th Annual Meeting of the Society of Neuroscience , Washington DC, November 15, 2008.
Frautschy, SA et al. Omega 3 DHA and a bioavailable curcumin formulation synergize for Alzheimer prevention. 39th Annual Meeting of the Society of Neuroscience , Chicago, IL October 2009.
Frautschy, SA et al. Efficacy of Longvida® in relation to systemic availability in the brain. 39th Annual Meeting of the Society of Neuroscience , Chicago, IL October 2009.
Gota et al. afety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Ag Food Chem 2010 58(4): 2095-2099.
Ray B, Lahiri DK. Neuroinflammation in Alzheimer’s disease: different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol. 2009 Aug;9(4):434-44.